These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28290211)

  • 1. Influence of hematuria and infection on diagnostic accuracy of urinary LASP1: a new biomarker for bladder carcinoma.
    Butt E; Ebbing J; Bubendorf L; Ardelt P
    Biomark Med; 2017 Apr; 11(4):347-357. PubMed ID: 28290211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LASP-1, a novel urinary marker for detection of bladder cancer.
    Ardelt P; Grünemay N; Strehl A; Jilg C; Miernik A; Kneitz B; Butt E
    Urol Oncol; 2013 Nov; 31(8):1591-8. PubMed ID: 22481019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective external validation of a bladder cancer detection model.
    Lotan Y; Svatek RS; Krabbe LM; Xylinas E; Klatte T; Shariat SF
    J Urol; 2014 Nov; 192(5):1343-8. PubMed ID: 24859442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross Hematuria.
    Dahmcke CM; Steven KE; Larsen LK; Poulsen AL; Abdul-Al A; Dahl C; Guldberg P
    Eur Urol; 2016 Dec; 70(6):916-919. PubMed ID: 27417036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hematuria in urothelial neoplasia.
    Shenoy UA; Schumann GB; DeBellis CC
    Am J Clin Pathol; 1986 Jan; 85(1):80-2. PubMed ID: 3940425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
    Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
    Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural network using combined urine nuclear matrix protein-22, monocyte chemoattractant protein-1 and urinary intercellular adhesion molecule-1 to detect bladder cancer.
    Parekattil SJ; Fisher HA; Kogan BA
    J Urol; 2003 Mar; 169(3):917-20. PubMed ID: 12576812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The application of BTA stat in the diagnosis of bladder tumor and hematuria].
    Wang X; Xu K; Zhu J; Hou S
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):228-30. PubMed ID: 11829827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--screening for urothelial cancer in patients with microscopic hematuria. NMP Study Group].
    Akaza H; Miyanaga N; Tsukamoto T; Ishikawa S; Noguchi R; Ohtani M; Kawabe K; Kubota Y; Fujita K; Obata K; Hirao Y; Kotake T; Ohmori H; Kumazawa J; Koiso K
    Gan To Kagaku Ryoho; 1997 May; 24(7):837-42. PubMed ID: 9170522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does subdivision of the "atypical" urine cytology increase predictive accuracy for urothelial carcinoma?
    Bostwick DG; Hossain D
    Diagn Cytopathol; 2014 Dec; 42(12):1034-44. PubMed ID: 24838797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected urothelial tumor in a young boy with asymptomatic hematuria.
    Ceccarelli PL; Caponcelli E; DI Pietro C; Biondini D; Bagni I; Cacciari A
    Minerva Pediatr; 2016 Oct; 68(5):385-7. PubMed ID: 27467106
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic tests in urology: urine cytology.
    Lavallée LT; Fergusson D; Dahm P; Scales CD; Witiuk K; Breau RH
    BJU Int; 2012 Dec; 110(11 Pt C):E789-91. PubMed ID: 23106855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients.
    Zhu X; Qiao Y; Liu W; Wang W; Shen H; Lu Y; Hao G; Zheng J; Tian Y
    Tumour Biol; 2016 Apr; 37(4):4569-77. PubMed ID: 26503215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive values of urinary bladder tumor markers survivin and soluble-Fas comparison with cystoscopy and bladder tumor antigen.
    Ganas V; Kalaitzis C; Sountoulides P; Giannakopoulos S; Touloupidis S
    Minerva Urol Nefrol; 2012 Dec; 64(4):279-85. PubMed ID: 23288215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer.
    Mbeutcha A; Lucca I; Mathieu R; Lotan Y; Shariat SF
    Urol Clin North Am; 2016 Feb; 43(1):47-62. PubMed ID: 26614028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary dosage of nuclear matrix protein 22 (NMP22) like biologic marker of transitional cell carcinoma (TCC): a study on patients with hematuria.
    Paoluzzi M; Cuttano MG; Mugnaini P; Salsano F; Giannotti P
    Arch Ital Urol Androl; 1999 Feb; 71(1):13-8. PubMed ID: 10193018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria.
    O'Sullivan P; Sharples K; Dalphin M; Davidson P; Gilling P; Cambridge L; Harvey J; Toro T; Giles N; Luxmanan C; Alves CF; Yoon HS; Hinder V; Masters J; Kennedy-Smith A; Beaven T; Guilford PJ
    J Urol; 2012 Sep; 188(3):741-7. PubMed ID: 22818138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Use and Promise of Urinary Markers for Urothelial Cancer.
    Tabayoyong W; Kamat AM
    Curr Urol Rep; 2018 Oct; 19(12):96. PubMed ID: 30328534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.